HUMA - Humacyte to Host Virtual KOL Event Hemodialysis Access: A Crossroads of Care on March 28 2024 | Benzinga
DURHAM, N.C., March 26, 2024 (GLOBE NEWSWIRE) -- Humacyte, Inc. (NASDAQ:HUMA), a clinical-stage biotechnology platform company developing universally implantable, bioengineered human tissue at commercial scale, today announced it will host a virtual KOL event on Thursday, March 28, 2024 at 8:00 AM ET, featuring Timmy Lee, MD, MSPH (University of Alabama at Birmingham) and Prabir Roy-Chaudhury MD, PhD, FRCP (University of North Carolina School of Medicine) who will discuss the profiles of patients receiving an AV Access who have higher rates of complications and the associated costs of treating them. To register, click here.
| Title |
| Hemodialysis Access: A Crossroads of Care Confronting Complications, Challenges, and Costs with Innovation |
| Date |
| Thursday, March 28, 2024 |
| Time |
| 8:00 AM Eastern Time |
| Webcast |
| Click Here |
Humacyte recently announced that the U.S. Food and Drug ...